Journal profile · Medicine-Oncology
JAMA Oncology
ISSN 2374-2437 · eISSN 2374-2445 · American Medical Association · UNITED STATES
JAMA Oncology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 23.19; hybrid open access; 337 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JAMA Oncology is published by American Medical Association and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Economic and Financial Impacts of Cancer, together about 22.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
Source: LetPub
Research area (LetPub): Medicine-Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine7.6%
- Lung Cancer Treatments and MutationsMedicine7.6%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance6.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.1%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.9%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance5.2%
- Prostate Cancer Treatment and ResearchMedicine4.8%
- Global Cancer Incidence and ScreeningMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Oncology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 23.19LetPub ·
- CiteScore 2026-06
- 32.6LetPub ·
- SJR 2026-06
- 7.4LetPub ·
- SNIP 2026-06
- 5.31LetPub ·
- h-index
- 61LetPub ·
- h-index
- 248OpenAlex ·
- i10-index
- 2,031OpenAlex ·
- 2-year mean citedness
- 8.48OpenAlex ·
- Self-citation rate
- 1.7%LetPub ·
- Share of gold OA articles
- 26.58%LetPub ·
Volume
- Articles per year
- 109LetPub ·
Articles by year OpenAlex count · 4,881 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 245 | 97 | 244 |
| 2025 | 337 | 155 | 2,087 |
| 2024 | 383 | 187 | 5,851 |
| 2023 | 362 | 190 | 11,365 |
| 2022 | 418 | 218 | 13,523 |
| 2021 | 419 | 219 | 21,508 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Medical Association
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2374-2437
- Electronic ISSN
- 2374-2445
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JAMA Oncology
What CAS zone is JAMA Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, JAMA Oncology is in Zone 1 of Medicine, and in Zone 1 of the minor category Oncology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JAMA Oncology?
The latest impact factor listed by LetPub is 23.19; CiteScore 32.6, h-index 248.
Which databases index JAMA Oncology?
According to LetPub and DOAJ records, JAMA Oncology is indexed in SCIE and Scopus.
Is JAMA Oncology open access, and what is the APC?
JAMA Oncology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .